Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3715_Библиотеки_им_академика_М_И_Перельмана
.pdf
References
https://t.me/medicina_free
345
20.3.15 Evolution andPatterns ofConstriction According
toAetiology
Permayer-Miralda and associates, in a prospective follow-up of patients with acute
pericardial disease, documented 56%, 35% and 17% prevalence of development of
severe subacute constriction requiring pericardiectomy following tuberculous,
purulent, and neoplastic pericarditis respectively. All the patients had subacute constriction, developing within six months of follow up. Patients with subacute constriction are more likely to have a specic cause for pericarditis than an idiopathic
aetiology. Transient constriction is seen more frequently in patients with idiopathic
pericarditis (with a prevalence of 20%). In cases of tuberculous, purulent or neoplastic pericarditis, severe constriction will predominate, while it is mild in idiopathic pericarditis. Knowledge of about these differences in presentation of
constrictive pericarditis due to various aetiology helps in establishing diagnosis [139].
References
1. Aggeli C, Pitsavos C, Brili S, Hasapis D, Frogoudaki A, Stefanadis C, Toutouzas P.Relevance
of adenosine deaminase and lysozyme measurements in the diagnosis of tuberculous pericarditis. Cardiology. 2000;94:81–5.
2. Alzeer AH, Fitxgerald JM.Corticosteroids and tuberculosis: risks and use as adjuvant therapy. Tubercle Lung Dis. 1993;74:6–11.
3. Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J, Brucato A,
Gueret P, Klingel K, Lionis C, Maisch B, Mayosi B, Pavie A, Ristic AD, Sabaté Tenas M,
Seferovic P, Swedberg K, Tomkowski W, ESC Scientic Document Group. ESC guidelines
for the diagnosis and management of pericardial diseases: the task force for the diagnosis and management of pericardial diseases of the European Society of Cardiology (ESC)
endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart
J. 2015;2015(36):2921–64.
4. Admetlla M, Cequier A, Amer R, Javaloyas M, Sabate X, Gausi C.Acute idiopathic pericarditis: clinical features, development and complications: prospective study of 101 cases [in
Spanish]. Med Clin (Barc). 1985;85(14):563–7.
5. Burgess LJ, Reuter H, Carstens ME, Taljaard JJ, Doubell AF.Cytokine production in patients
with tuberculous pericarditis. Int J Tuberc Lung Dis. 2002;6:439–46.
6. Burgess LJ, Reuter H, Carstens ME, Taljaard JJF, Doubell AF. The use of adenosine
deaminase and interferon-gamma as diagnostic tools for tuberculous pericarditis. Chest.
2002;122:900–5.
7. Brisson-Noël A, Gicquel B, Le Coissier D, Lévy-Frébault V, Nassif X, Hance AJ.Rapid diagnosis of tuberculosis by amplication of mycobacterial DNA in clinical samples. Lancet.
1989;2:1069–71.
8. Burgess LJ, Reuter H, Taljaard JJF, Doubell AF.Role of biochemical tests in the diagnosis of
large pericardial effusions. Chest. 2002;121:495–9.
9. Becit N, Unlu Y, Ceviz M, Kocogullari CU, Kocak H, Gurlertop Y.Subxiphoid pericardiostomy in the management of pericardial effusions: case series analysis of 368 patients. Heart.
2005;91:785–90.
10. Bhan GL.Tuberculous pericarditis. J Infect. 1980;2:360–4.
346
https://t.me/medicina_free
11. Bashi VV, John S, Ravikumar E, Jairaj PS, Shyamsunder K, Krishnaswami S.Early and late
results of pericardiectomy in 118 cases of constrictive pericarditis. Thorax. 1988;43:637–41.
12. Barnes PF, Le HQ, Davidson PT.Tuberculosis in patients with HIV infection. Med Clin N
Am. 1993;77:1369–90.
13. Bush CA, Stang JM, Wooley CF, Kilman JW. Occult constrictive pericardial disease.
Diagnosis by rapid volume expansion and correction by pericardiectomy. Circulation.
1977;56:924–30.
14. Cegielski JP, Lwakatare J, Dukes CS.Tuberculous pericarditis in Tanzanian patients with and
without HIV infection. Tuber Lung Dis. 1994;75:429–34.
15. Cegielski JP, Ramaiya K, Lallinger GJ, Mtulia IA, Mbaga IM.Pericardial disease and human
immunodeciency virus in Dar Es Salaam. Tanzania Lancet. 1990;335:209–12.
16. Chaison RE, Schecter GF, Theuer CP, Rutherford GW, Echenberg DF, Hopewell
PC.Tuberculosis in patients with acquired immunodeciency syndrome. Am Rev Resp Dis.
1987;136:570–4.
17. Corey GR, Campbell PT, van Trigt P, Kenney RT, O’Connor CM, Sheikh KH, Kisslo JA, Wall
TC.Aetiology of large pericardial effusions. Am J Med. 1993;95:209–13.
18. Commerford PJ, Strang JIG.Tuberculous pericarditis. In: Coovadia HM, Benatar SR, editors.
A century of tuberculosis: south African perspectives. Cape Town: Oxford University Press;
1991. p.123–36.
19. Commerford P, Mayosi B.An appropriate research agenda for heart disease in Africa. Lancet.
2006;367:1884–6.
20. Cherian G. Diagnosis of tuberculous aaetiology in pericardial effusion. Postgrad Med
J. 2004;80:262–6.
21. Cherian G, Habashy AG, Uthaman B, Cherian JM, Salama A, Anim JT.Detection and follow up of mediastinal lymph node enlargement in tuberculous pericardial effusions using computed tomography. Am J Med. 2003;114:319–22.
22. Chowdhury UK, Kumari LS, Hasija S.Surgery for chronic constrictive pericarditis, tuberculous pericarditis and effusive-constrictive pericarditis. Cardiological Society of India, 2018.
Essentials of Postgraduate Cardiology, Evangel Publishers, Invited Chapter 64, pp.1–10.
23. Chowdhury UK, Subramaniam G, Kumar AS, Airan B, Singh R, Talwar S, et al.
Pericardiectomy for constrictive pericarditis: clinical, echocardiographic and haemodynamic
evaluation of two surgical techniques. Ann Thorac Surg. 2006;81:522–30.
24. Chowdhury UK, Kumari LS.Pericardiectomy for chronic constrictive pericarditis: where are
we after 100 years? World J Surgery and Surgical Res. 2018;1:1027–30.
25. Chowdhury UK, Patel K, Kumari L, Seth S, Avneesh S, Mishra AK, Kalaivani M, Hasija
S.Tissue Doppler imaging-derived mitral and tricuspid annular velocities: non-predictors of
operative outcome in patients undergoing pericardiectomy for chronic constrictive pericarditis. Journal of Cardiology and Diagnostic Research. 2019;2(2):67–83.
26. Chowdhury UK, Seth S, Reddy SM.Pericardiectomy for chronic constrictive pericarditis. J
Operative Tech Thorac Cardiovasc Surg. 2008;13:14–25.
27. Chowdhury UK, George N, Singh S, Sankhyan LK, Sengupta S, Ray R, Vaswani P, etal.
Total pericardiectomy via modied left anterolateral thoracotomy without cardiopulmonary
bypass: a video presentation. Ann Thorac Surg. 2021;112:1483–92. https://doi.org/10.1016/j.
athoracsur.2020.10.045.
28. Chowdhury UK, Narang R, Malhotra P, Choudhury M, Choudhury A, Singh SP.Indications,
timing and techniques of radical pericardiectomy via modied left anterolateral thoracotomy (UKC’s modication) and total pericardiectomy via median sternotomy (Holman and
Willett) without cardiopulmonary bypass. J Prac Cardiovasc Sci. 2016;2:17–27.
29. Critchley JA, Young F, Orton L, Gamer P. Corticosteroids. For prevention of mortality
in people with tuberculosis. A systematIc review and meta-analysis. Lancet Infect Dis.
2013;13:223–37.
20 Specic Disease Entities
References
https://t.me/medicina_free
30. Churchyard GJ, Fielding K, Charalambous S, Day JH, Corbett EL, Hayes RJ, etal. Efcacy
of secondary isoniazid preventive therapy among HIV-infected southern Africans: time to
change policy? AIDS. 2003;12:2063–70.
31. Cameron J, Oesterle SN, Baldwin JC, Hancock EW.The etiologic spectrum of constrictive
pencarditis. Am Heart J. 1987;113:354–60.
32. Carmichael DB, Sprague HB, Wyman SM, Bland EF.Acute nonspecic pericarditis: clinical,
laboratory, and follow-up considerations. Circulation. 1951;3(3):321–31.
33. Diog JC, Hilton CJ, Reid DS.Salmonella: a rare cause of subacute effusive-constrictive pericarditis. Br Heart J. 1991;65:296–7.
34. Desai HN.Tuberculous pericarditis: a review of 100 cases. S Afr Med J. 1979;55:877–80.
35. Ewer K, Deeks J, Alvarez L, Bryant G, Waller S, Andersen P, Monk P,Lalvani A. Comparison
of T-cell-based assay with tuberculin skin test for diagnosis of mycobacterium tuberculosis
infection in a school tuberculosis outbreak. Lancet. 2003;361:1168–73.
36. Fowler NO.Tuberculous pericarditis. J Am Med Assoc. 1991;266:99–103.
37. Fowler NO, Manitsas GT.Infectious pericarditis. Prog Cardiovasc Dis. 1973;16:323–36.
38. Fowler NO. Constrictive pericarditis: its history and current status. Clin Cardiol.
1995;18:341–50.
39. Fowler NO.Constrictive pericarditis: new aspects. Am J Cardiol. 1982;50:1014–7.
40. Francone M, Dymarkowski S, Kalantzi M, Bogaert J.Magnetic resonance imaging in the
evaluation of the pericardium. A pictorial essay. Radiol Med. 2005;109:64–74.
41. Francone M, Dymarkowski S, Kalantzi M, Bogaert J.Real-time cine MRI of ventricular
septal motion. A novel approach to assess ventricular coupling. J Magn Reson Imaging.
2005;21:305–9.
42. Francone M, Dymarkowski S, Kalantzi M, Rademakers FE, Bogaert J.Assessment of ventricular coupling with real-time cine MRI and its value to differentiate constrictive pericarditis from restrictive cardiomyopathy. Eur Radiol. 2006;16(4):944–51.
43. Francone M, Dymarkowski S, Kalantzi M, Rademarkers FE, Bogaert J.Real-time cine MRI
of ventricular septal motion: a novel approach to assess ventricular coupling. J Magn Reson
Imaging. 2005;21:305–9.
44. Fennell WMP. Surgical treatment of constrictive tuberculous pericarditis. S Afr Med
J. 1982;62:353–5.
45. Gibbs CR, Watson RD, Singh SP, Lip GY.Management of pericardial effusion by drainage: a
survey of 10 years, experience in a city Centre general hospital serving a multiracial population. Postgrad Med J. 2000;76:809–13.
46. Gabriel L, Shelburne JC. “Acute” granulomatous pericarditis. Clinical and haemodynamic
correlate. Chest. 1997;71:473–8.
47. Godfrey-Faussett P, Wilkins EGL, Khoo S, Stoker N.Tuberculous pericarditis conrmed by
DNA amplication. Lancet. 1991;337:176–7.
48. Gooi HC, Smith JM.Tuberculous pericarditis in Birmingham. Thorax. 1978;33:94–6.
49. George S, Salama AL, Uthaman B, Cherian G.Echocardiography in differentiating tuberculous from chronic idiopathic pericardial effusion. Heart. 2004;90:1338–9.
50. George TJ, Arnaoutakis GJ, Beaty CA, Kilic A, Baumgartner WA, Conte JV.Contemporary
aaetiologies, risk factors and outcomes after pericardiectomy. Ann Thorac Surg.
2012;94:445–51.
51. Garner P, Holmes A.Treating tuberculosis. Clin Evid Concise. 2002;7:146–7.
52. Grieco MH, Chmel H.Acute disseminated tuberculosis as a diagnostic problem: a clinical
study based on twenty-eight cases. Am Rev Resp Dis. 1974;109:554–60.
53. Galve E, Permanyer-Miralda G, Tornos MP, Oller G, Roma F, Soler-Soler J.Self limited acute
pericarditis as initial manifestation of primary cardiac tumor. Am Heart J. 1992;123(6):1690–2.
54. Greason K, Danielson GK, Oh JK, Nishimura RA. Pericardiectomy for chronic relapsing
pericarditis. J Am Coll Cardiol. 2001;37:478–9.
55. Hakim JG, Manyemba J.Cardiac disease distribution among patients referred for echocardiography in Harare. Zimbabwe Cent Afr J Med. 1998;44:140–4.
347
348
https://t.me/medicina_free
56. Hakim JG, Temouth I, Mushangi E, Siziya S, Robertson V, Malin A.Double blind randomised
placebo controlled trial of adjunctive prednisolone in the treatment of effusive tuberculous
pericarditis in HIV seropositive patients. Heart. 2000;84:183–8.
57. Hageman JH, d’Esopo ND, Glenn WWL.Tuberculosis of the pericardium: a long-term analysis of forty-four proved cases. N Engl J Med. 1964;270:327–32.
58. Ha JW, Oh JK, Ommen SR, Ling LH, Tajik AJ.Diagnostic value of mitral annular velocity
for constrictive pericarditis in the absence of respiratory variation in mitral inow velocity. J
Am Soc Echocardiogr. 2002;15:1468–71.
59. Hayashi H, Kawamata H, Machida M, Kumazaki T.Tuberculous pericarditis: MRI features
with contrast enhancement. Br J Radiol. 1998;71:680–2.
60. Ha JW, Oh JK, Schaff HV, Ling LH, Higano ST, Mahoney DW, Nishimura RA.Impact of left
ventricular function on immediate and long-term outcomes after pericardiectomy in constrictive pericarditis. J Thorac Cardiovasc Surg. 2008;136:1136–41.
61. Hurrell DG, Nishimura RA, Higano ST, Appleton CP, Danielson GK, Holmes DR Jr, Tajik
AJ.Value of dynamic respiratory changes in left and right ventricular pressures for the diagnosis of constrictive pericarditis. Circulation. 1996;93:2007–13.
62. Ha JW, Ommen SR, Tajik AJ, Barnes ME, Ammash NM, Gertz MA, Seward JB, Oh
JK.Differentiation of constrictive pericarditis from restrictive cardiomyopathy using mitral
annular velocity by tissue Doppler echocardiography. Am J Cardiol. 2004;94:316–9.
63. Ha CB, Huh JY, Shin YW, Shin YK.Doppler ow patterns of constrictive pericarditis. Korean
Circ J. 1989;19:47–54.
64. Hancock EW. On elastic and rigid forms of constrictive pericarditis. Am Heart
J. 1980;100:917–23.
65. Ha JW, Ko YG, Choi BW.Images in cardiology. Delayed hyperenhancement of the pericardium by magnetic resonance imaging as a marker of pericardial inammation in a patient
with tuberculous effusive constrictive pericarditis. Heart. 2006;92:494.
66. Harvey AM, Whitehill MR.Tuberculous pericarditis. Medicine. 1937;16:45–94.
67. Ha JW, Oh JK, Ling LH, Nishimura RA, Seward JB, Tajik AJ.Annulus paradoxus: transmitral ow velocity to mitral annular velocity ratio is inversely proportional to pulmonary capillary wedge pressure in patients with constrictive pericarditis. Circulation. 2001;104:976–8.
68. Hansen AT, Eskildsen P, Göotzsche H.Pressure curves from the right auricle and the right
ventricle in chronic constrictive pericarditis. Circulation. 1961;3:881–8.
69. Hugo-Hamman CT, Scher H, De Moor MM.Tuberculous pericarditis in children: a review of
44 cases. Pediatr Infect Dis J. 1994;13:13–8.
70. Harvey RM, Ferrer MI, Cathcart RT, Richards DW, Cournand A.Mechanical and myocardial
factors in chronic constrictive pericarditis. Circulation. 1953;8:695–707.
71. Hancock EW. A clearer view of effusive-constrictive pericarditis. N Engl J Med.
2004;350:435–7.
72. Hancock EW.Neoplastic pericardial disease. Cardiol Clin. 1990;8:673–82.
73. Hancock EW.Subacute effusive constrictive pericarditis. Circulation. 1971;43:183–92.
74. Harrington SW.Chronic constrictive pericarditis: partial pericardiectomy and epicardiolysis
in twenty-four cases. Ann Surg. 1944;120:468–85.
75. Imazio M, Brucato A, Derosa FG, Lestuzzi C, Bombana E, Scipione F, Leuzzi S, Cecchi E,
Trinchero R, Adler Y.Aetiological diagnosis in acute and recurrent pericarditis: when and
how. J Cardiovasc Med. 2009;10:217–30.
76. Imazio M, Brucato A, Maestroni S, Cumetti D, Belli R, Trinchero R, Adler Y.Risk of constrictive pericarditis after acute pericarditis. Circulation. 2011;124:1270–5.
77. Imazio M, Brucato A, Trinchero R, Adler Y.Diagnosis and management of pericardial diseases. Nat Rev Cardiol. 2009;6:743–51.
78. Imazio M, Cecchi E, Demichelis B, Ierna S, Demarie D, Ghisio A, Pomari F, Coda L,
Belli R, Trinchero R. Indicators of poor prognosis of acute pericarditis. Circulation.
2007;115(21):2739–44.
20 Specic Disease Entities
References
https://t.me/medicina_free
79. Imazio M, Spodick DH, Brucato A, Trinchero R, Adler Y.Controversial issues in the management of pericardial diseases. Circulation. 2010;121:916–28.
80. Imazio M, Trinchero R.Clinical management of acute pericardial disease: a review of results
and outcomes. Ital Heart J. 2004;5:803–17.
81. Imazio M, Trinchero R. Myopericarditis: aetiology, management, and prognosis. Int J
Cardiol. 2008;127:17–26.
82. Imazio M, Trinchero R.The spectrum of inammatory myopericardial diseases. Int J Cardiol.
2010;144(1):134.
83. Imazio M, Trinchero R. Triage and management of acute pericarditis. Int J Cardiol.
2007;118:286–94.
84. Imazio M, Bobbio M, Cecchi E, Demarie D, Demichelis B, Pomari F, Moratti M, Gaschino
G, Giammaria M, Ghisio A, Belli R, Trinchero R. Colchicine in addition to conventional
therapy for acute pericarditis: results of the colchicine for acute pericarditis (COPE) trial.
Circulation. 2005;112(13):2012–6.
85. Imazio M, Bobbio M, Cecchi E, Demarie D, Pomari F, Moratti M, Ghisio A, Belli R,
Trinchero R.Colchicine as rst choice therapy for recurrent pericarditis. Arch Intern Med.
2005;165:1987–91.
86. Imazio M, Brucato A, Adler Y, Brambilla G, Artom G, Cecchi E, Palmieri G, Trinchero
R.Prognosis of idiopathic recurrent pericarditis as determined from previously published
reports. Am J Cardiol. 2007;100:1026–8.
87. Imazio M, Brucato A, Cumetti D, Brambilla G, Demichelis B, Ferro S, Maestroni S, Cecchi
E, Belli R, Palmieri G, Trinchero R.Corticosteroids for recurrent pericarditis: high versus
low doses: a nonrandomized observation. Circulation. 2008;118:667–71.
88. Imazio M, Brucato A, Trinchero R, Shabetai R, Spodick D, Adler Y.Corticosteroid therapy
for pericarditis: a double-edged sword. Nat Clin Pract Cardiovasc Med. 2008;5(3):118–9.
89. Imazio M, Cecchi E, Correndo L, D’Oulx EA, Doronzo B, Trinchero R.Treatment of refractory recurrent pericarditis. J Cardiovasc Med. 2007;8:748–53.
90. Imazio M, Cecchi E, Demichelis B, Chinaglia A, Ierna S, Demarie D, Ghisio A, Pomari F,
Belli R, Trinchero R.Myopericarditis versus viral or idiopathic acute pericarditis. Heart.
2008;94(4):498–501.
91. Imazio M, Demichelis B, Cecchi E, Belli R, Ghisio A, Bobbio M, Trinchero R.Cardiac troponin I in acute pericarditis. J Am Coll Cardiol. 2003;42(12):2144–8.
92. Imazio M, Demichelis B, Parrini I, Cecchi E, Demarie D, Ghisio A, Belli R, Bobbio M,
Trinchero R.Management, risk factors, and outcomes in recurrent pericarditis. Am J Cardiol.
2005;96:736–9.
93. Imazio M, Demichelis B, Parrini I, Cecchi E, Pomari F, Demarie D, Gaschino G, Ghisio A,
Belli R, Trinchero R.Recurrent pain without objective evidence of disease in patients with
previous idiopathic or viral acute pericarditis. Am J Cardiol. 2004;94(7):973–5.
94. Imazio M, Demichelis B, Parrini I, Giuggia M, Cecchi E, Gaschino G, Demarie D, Ghisio A,
Trinchero R.Day-hospital treatment of acute pericarditis: a management program for outpatient therapy. J Am Coll Cardiol. 2004;43(6):1042–6.
95. Imazio M, Spodick DH, Brucato A, Trinchero R, Markel G, Adler Y.Diagnostic issues in the
clinical management of pericarditis. Int J Clin Pract. 2010;64:1384–92.
96. Imazio M, Trinchero R, Shabetai R.Pathogenesis, management, and prevention of recurrent
pericarditis. J Cardiovasc Med. 2007;8:404–10.
97. Imazio M.Asymptomatic postoperative pericardial effusions: against the routine use of antiinammatory therapy. Ann Intern Med. 2010;152:186–7.
98. Jain S, Sharma N, Varma S, Rajwanshi JS, Verma JS, Sharma BK.Prole of cardiac tamponade in the medical emergency ward of a north Indian hospital. Can J Cardiol. 1999;15:671–5.
99. Khandaker MH, Khandaker MH, Espinosa RE, Nishimura RA, Sinak LJ, Hayes SN, Melduni
RM, etal. Pericardial disease: diagnosis and management. Mayo Clin proc. in Mayo Clinic
proceedings, Elsevier 2010; 85(6): 572, 593.
349
350
https://t.me/medicina_free
100. Klein C, Graf K, Fleck E, Nagel E.Acute brinous pericarditis assessed with magnetic resonance imaging. Images in cardiovascular medicine Circulation. 2003;107:e82.
101. Khera G, Chowdhury V, Singh S, Dixit R.Magnetic resonance imaging of effusive constrictive pericarditis. Indian Heart J. 2005;57:780–2.
102. LeWinter MM, Kabbani S.Pericardial diseases. In: Zipes DP, Libby P, Bonow RO, Braunwald
E, editors. Braunwald’s heart disease. 7th ed. Philadelphia, PA: Elsevier Saunders; 2005.
p.1757–80.
103. Little WC, Freeman GL.Pericardial disease. Circulation. 2006;113:1622–32.
104. Ling LH, Oh JK, Schaff HV, Danielson GK, Mahoney OW, Seward JB, Tajik JA.Constrictive
pericarditis in the modern era: evolving clinical spectrum and impact on outcome after pericardiectomy. Circulation. 1999;100:1380–6.
105. Ling LH, Oh JK, Breen JF, Schaff JV, Danielson GK, Mahoney DW, Seward JB, Tajik
AJ.Calcic constrictive pericarditis: is it still with us? Ann Intern Med. 2000;132:444–50.
106. Larrieu AJ, Tyers GF, Williams EH, Derrick JR.Recent experience with tuberculous pericarditis. Ann Thorac Surg. 1980;29:464–8.
107. Lee JH, Lee CW, Lee SG, Yang HS, Hong MK, Kim JJ, Park SW, Chi HS, Park SL.Comparison
of polymerase chain reaction with adenosine deaminase activity in pericardial uid for the
diagnosis of tuberculous pericarditis. Am J Med. 2002;113:519–21.
108. Latouf SE, Ress SR, Lukey PT, Commerford PJ.Interferongamma in pericardial aspirates:
a new, sensitive and specic test for the diagnosis of tuberculous pericarditis. Circulation.
1991;84:II-149.
109. Latouf SE, Levetan BN, Commerford PJ.Tuberculous pericardial effusion: analysis of commonly used diagnostic methods. S Afr Med J. 1996;86(suppl):15.
110. Lange RA, Hillis LD.Clinical practice. Acute pericarditis N Engl J Med. 2004;351:2195–202.
111. Liu S, Ma C, Ren W, Zhang J, Li N, Yang J, Zhang Y, Qiao W. Regional left atrial function differentiation in patients with constrictive pericarditis and restrictive cardiomyopathy: a
study using speckle tracking echocardiography. Int J Cardiovasc Imaging. 2015;31:1529–36.
https://doi.org/10.1007/s10554- 015- 0726- 7.
112. Maisch B, Seferović PM, Ristić AD, Erbel R, Rienmüller R, Adler Y, Tomkowski WZ, Thiene
G, Yacoub MH, Priori SG, Alonso Garcia MA.Guidelines on the diagnosis and management
of pericardial diseases executive summary: the task force on the diagnosis and management of
pericardial diseases of the European Society of Cardiology. Eur Heart J. 2004;25(7):587–610.
113. Mayosi BM, Burgess LJ, Doubell AF. Tuberculous pericarditis. Circulation.
2005;112(23):3608–16.
114. Mayosi BM, Wiysonge CS, Ntsekhe M, etal. Clinical characteristics and initial management
of patients with tuberculous pericarditis in the HIV era: the investigation of the management
of pericarditis in Africa (IMPI Africa) registry. BMC Infect Dis. 2006;6:2.
115. Mayosi BM, Wiysonge CS, Ntsekhe M, Gumedze F, Volmink JA, Maartens G, Aje A, Thomas
BM, Thomas KM, Awotedu AA, Thembela B.Mortality in patients treated for tuberculous
pericarditis in sub-Saharan Africa. South Afr Med J. 2008;98(1):36–40.
116. Mayosi BM.Contemporary trends in the epidemiology and management of cardiomyopathy
and pericarditis in sub-Saharan Africa. Heart. 2007;93(10):1176–83.
117. Maher D, Harries AD.Tuberculous pericardial effusion: a prospective clinical study in a lowresource setting-Blantyre. Malawi Int J Tubercul Lung Dis. 1997;1(4):358–64.
118. Maisch B, Bethge C, Drude L, Hufnagel G, Herzum M, SchÜnian U.Pericardioscopy and
epicardial biopsy- new diagnostic tools in pericardial and perimyocardial disease. Eur Heart
J. 1994;15:68–73.
119. Mayosi BM, Ntsekhe M, Volmink JA, Commerford PJ. Interventions for treating tuberculous pericarditis. Cochrane Database Syst Rev. 2002;4:CD000526. https://doi.
org/10.1002/14651858.CD000526.
120. Maisch B, Maisch S, Kochsiek K.Immune reactions in tuberculous and chronic constrictive pericarditis: clinical data and diagnostic signicance of antimyocardial antibodies. Am J
Cardiol. 1982;50(5):1007–13.
20 Specic Disease Entities
References
https://t.me/medicina_free
121. Maisch B, Ristić AD, Rupp H, Spodick DH.Pericardial access using the PerDUCER and
exible percutaneous pericardioscopy. Am J Cardiol. 2001;88(11):1323–6.
122. Mayosi BM, Ntsekhe M, Bosch J, Pandie S, Jung H, Gumedze F, Pogue J, Thabane L, Smieja
M, Francis V, Joldersma L.Prednisolone and Mycobacterium indicus pranii in tuberculous
pericarditis. New Eng J Med. 2014;371(12):1121–30.
123. Misselt AJ, Harris SR, Glockner J, Feng D, Syed IS, Araoz PA.MR imaging of the pericardium. Mag Resonance Imag Clin North Am. 2008;16(2):185–99.
124. McCaughan BC, Schaff HV, Piehler JM, Danielson GK, Orszulak TA, Puga FJ, Pluth JR,
Connolly DC, McGoon DC.Early and late results of pericardiectomy for constrictive pericarditis. J Thorac Cardiovasc Surg. 1985;89(3):340–50.
125. Mellors JW, Munoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, et al. Plasma viral
load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med.
1997;126:946–54.
126. Maisch B. Recurrent pericarditis: mysterious or not so mysterious? Eur Heart
J. 2005;26(7):631–3.
127. Norris GW.Tuberculous pericarditis based on a study of 7,219 autopsies in Philadelphia
hospitals. Univ Penn M Bull. 1904;17:155.
128. Ng AS, Dorosti K, Sheldon WC. Constrictive pericarditis following cardiac surgeryCleveland Clinic experience: report of 12 cases and review. Cleve Clin Q. 1984;51(1):39–45.
129. Narain JP, Raviglione M, Kochi A.HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention. Tubercle Lung Dis. 1992;73:311–21.
130. Ntsekhe M, Wiysonge CS, Gumedze F, Maartens G, Commerford PJ, Volmink JA, Mayosi
BM.HIV infection is associated with a lower incidence of constriction in presumed tuberculous pericarditis: a prospective observational study. PLoS One. 2008;3(6):e2253.
131. Ng TT, Strang JI, Wilkins EG.Humoral response to mycobacterial heat shock proteins in
patients with constrictive pericarditis caused by tuberculosis and its implications for pathogenesis. Clin Diagn Lab Immunol. 1994;1(5):552–5.
132. Ng TT, Strang JI, Wilkins EG.Serodiagnosis of pericardial tuberculosis. QJM Int J Med.
1995;88(5):317–20.
133. Ntsekhe M, Wiysonge C, Volmink JA, Commerford PJ, Mayosi BM.Adjuvant corticosteroids for tuberculous pericarditis: promising, but not proven. QJM. 2003;96(8):593–9.
134. Ntsekhe M, Hakim J.Impact of human immunodeciency virus infection on cardiovascular
disease in Africa. Circulation. 2005;112(23):3602–7.
135. Narita M, Ashkin D, Hollender ES, Pitchenik AE. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Resp Crit Care Med.
1998;158:157–61.
136. Oh KY, Shimizu M, Edwards WD, Tazelaar HD, Danielson GK.Surgical pathology of the parietal pericardium: a study of 344 cases (1993–1999). Cardiovasc Pathol. 2001;10(4):157–68.
137. Osler W.Tuberculous pericarditis. Am J Med Sci. 1893;105:20–37.
138. Ortbals DW, Avioli LV.Tuberculous pericarditis. Arch Intern Med. 1979;139:231–4.
139. Permanyer-Miralda G, Sagrista-Saileda J, Soler-SolerJ.Primary acute pericardial disease : a
prospectiveseries of 231 consecutive patients. Am J Cardiol. 1985;56:623–9.
140. Palella FJ Jr, Delaney KM, Moorman KC, Loveless MO, Fuhrer J, Satten GA, etal. Declining
morbidity and mortality among patients with advanced human immunodeciency virus infection. N Engl J Med. 1998;382:853–60.
141. Pozniak AL, Weinberg J, Mahari M, Neill P, Houston S, Latif A.Tuberculous pericardial
effusion associated with HIV infection: a sign of disseminated disease. Tuber Lung Dis.
1994;75(4):297–300.
142. Prout S, Benatar SR. Disseminated tuberculosis: a study of 62 cases. S Afr Med
J. 1980;58:835–42.
143. Quraishi AR, Khan AA, Kazmi KA, Najaf SM, Basir MN, Shafquat A, etal. Clinical and
echocardiographic characteristics of patients with signicant pericardial effusion requiring
pericardiocentesis. J Pak Med Assoc. 2005;55:66–70.
351
352
https://t.me/medicina_free
144. Reuter H, Burgess L, van Vuuren W, Doubell A.Diagnosing tuberculous pericarditis. Q J
Med. 2006;99:827–39.
145. Reuter H, Burgess LJ, Doubell AF.Epidemiology of pericardial effusions at a large academic
hospital in South Africa. Epidemiol Infect. 2005;133:393–9.
146. Reuter H, Burgess LJ, Louw VJ, Doubell AF.The management of tuberculous pericardial
effusion: experience in 233 consecutive patients. Cardiovasc J S Afr. 2007;18:20–5.
147. Rooney JJ, Crocco JA, Lyons HA.Tuberculous pericarditis. Ann Intern Med. 1970;72:73–81.
148. Reuter H, Burgess LJ, Schneider J, Van Vururen W, Doubell AF.The role of histopathology in establishing the diagnosis of tuberculous pericardial effusions in the presence of
HIV.Histopathology. 2006;48:295–302.
149. Roberts WI, Spray TL.Pericardial heart disease: a study of its causes, consequences and morphologic features. In: Spodick DH, editor. Cardiovascular Clinics, vol. 7(3). Philadelphia:
F.A.Davis; 1976. p.11–68.
150. Reuter H, Burgess LJ, Carstens ME, Doubell AF.Adenosine deaminase activity: more than a
diagnostic tool in tuberculous pericarditis. Cardiovasc J South Afr. 2005;16:143–7.
151. Rodriguez E, Soler R, Juffe A, Salgado L.CT and MR ndings in a calcied myocardial
tuberculoma of the left ventricle. J Comput Assist Tomogr. 2001;25:577–9.
152. Rienmuller R, Groll R, Lipton MJ.CT and MR imaging of pericardial disease. Radiol Clin
N Am. 2004;42:587–601.
153. Rienmuller R, Gurgan M, Erdmann E, Kemkes BM, Kreutzer E, Weinhold C.CT and MR
evaluation of pericardial constriction: a new diagnostic and therapeutic concept. J Thorac
Imaging. 1993;8:108–21.
154. Reuter H, Burgess LJ, Louw VJ, Doubell AF.Experience with adjunctive corticosteroids in
managing tuberculous pericarditis. Cardiovasc J S Afr. 2006;17:233–8.
155. Schrire V.Experience with pericarditis at Groote Schuur hospital, Cape Town: an analysis of
one hundred and sixty cases over a six-year period. S Afr Med J. 1959;33:810–7.
156. Seferovic PM, Ristic AD, Imazio M, Maksimovic R, Simeunovic D, Trinchero R, et al.
Management strategies in pericardial emergencies. Herz. 2006;31:891–900.
157. Shabetai R.Pericardial diseases. In: Hurst JW, editor. The heart, arteries and veins. NewYork:
McGraw-Hill; 1990. p.1348–74.
158. Shabetai R.The pericardium. Boston: Kluwer Academic; 2003. p.191–251.
159. Shabetai R.The pericardium. NewYork: Grone & Stratton; 1981.
160. Shabetai R.Diseases of the pericardium. In: Hurst JW, Schlant RC, Alexander RW, editors.
The heart: arteries and veins. 8. NewYork, NY: McGraw-Hill; 1994. p.1654–62.
161. Schrank JH Jr, Dooley DP.Purulent pericarditis caused by Candida species: case report and
review. Clin Infect Dis. 1995;21:182–7.
162. Spodick DH.Acute cardiac tamponade. N Engl J Med. 2003;349:684–90.
163. Spodick DH. Acute pericarditis: current concepts and practice. J Am Med Assoc.
2003;289:1150–3.
164. Spodick DH.Constrictive pericarditis. In: Spodick DH, editor. The pericardium: a comprehensive textbook. 1st ed. NewYork: Marcel Dekker, Inc; 1997. p.214–59.
165. Spodick DH.Pericardial macro-and microanatomy: a synopsis. In: Spodick DH, editor. The
pericardium: a comprehensive textbook. NewYork, NY: Marcel Dekker; 1997. p.7–14.
166. Spodick DH. The pericardium. A comprehensive textbook, vol. 233. New York, NY:
M.Dekker; 1997. p.464.
167. Sagrista-Sauleda J, Almenar Bonet L, Angel Ferrer J, Bardají Ruiz A, Bosch Genover X,
Guindo Soldevila J, et al. The clinical practice guidelines of the Sociedad Espanola de
Cardiologia on pericardial pathology. Rev Esp Cardiol. 2000;53:394–412.
168. Spodick DH.Pericardial diseases. In: Braunwald E, Zipes DP, Libby P, editors. Heart disease:
a textbook of cardiovascular medicine, vol. 6. Philadelphia, PA: WB Saunders Co; 2001.
p.1823–70.
169. Spodick DH.Infective pericarditis. Etiologic and clinical spectra. In: Reddy PS, Leon DF,
Shaver JA, editors. Pericardial disease. NewYork: Raven Press; 1982. p.307–32.
20 Specic Disease Entities
References
https://t.me/medicina_free
170. Spodick DH.Diagnostic electrocardiographic sequences in acute pericarditis: signicance of
PR segment and PR vector changes. Circulation. 1973;48:575–80.
171. Strang JI, Nunn AJ, Johnson DA, Casbard A, Gibson DG, Girling DJ.Management of tuberculous constrictive pericarditis and tuberculous pericardial effusion in Transkei: results at 10
years follow-up. QJM. 2004;97:525–35.
172. Strang JI.Tuberculous pericarditis in Transkei. Clin Cardiol. 1984;7:667–70.
173. Strang JIG. Tuberculous pericarditis. In: Campbell GD, Seedat YK, Daynes G, editors.
Clinical medicine and health in developing Africa. Cape Town: David Philip; 1982. p.145–9.
174. Syed FF, Mayosi BM.A modern approach to tuberculous pericarditis. Prog Cardiovasc Dis.
2007;50(3):218–36.
175. Schepers GWH.Tuberculous pericarditis. Am J Cardiol. 1962;9:248–76.
176. Spodick DH.Tuberculous pericarditis. Arch Intern Med. 1956;98:737–49.
177. Sagrista-Sauleda J, Angel J, Permanyer-Miralda G, Soler-Soler J. Long-term follow-up of
idiopathic chronic pericardial effusion. N Engl J Med. 1999;341:2054–9.
178. Sagrista-Sauleda J, Merce J, Permanyer-Miralda G, Soler-Soler J.Clinical clues to the causes
of large pericardial effusions. Am J Med. 2000;109:95–101.
179. Sagrista-Sauleda J, Permanyer-Miralda G, Soler-Soler J.Tuberculous pericarditis: ten year
experience with a prospective protocol for diagnosis and treatment. J Am Coll Cardiol.
1988;11:724–8.
180. Salem MH, Wilson JR.Tuberculous pericarditis. Evaluation of forty-seven cases at Duke
Hospital. J Int Coll Surg. 1960;33:535–41.
181. Sahn SA, Neff TA.Miliary tuberculosis. Am J Med. 1974;56:495–505.
182. Strang G, Latouf S, Commerford P, Roditi D, Duncan-TraiIl G, Barlow D, etal. Bedside
culture to conrm tuberculous pericarditis. Lancet. 1991;338:1600–1.
183. Strang JI, Kakaza HHS, Gibson DG, Allen BW, Mitchison DA, Evans DJ, etal. Controlled
clinical trial of complete open surgical drainage and of prednisolone in treatment of tuberculous pericardial effusion in Transkei. Lancet. 1988;2:759–64.
184. Strang JI.Rapid resolution of tuberculous pericardial effusions with high dose prednisone
and antituberculous drugs. J Infect. 1994;28:251–4.
185. Strang JI, Kakaza HH, Gibson DG, Girling DJ, Nunn AJ, Fox W.Controlled trial of prednisolone as adjuvant in treatment of tuberculous constrictive pericarditis in Transkei. Lancet.
1987;2:1418–22.
186. Sagrista-Sauleda J.Pericardial constriction: uncommon patterns. Heart. 2004;90:257–8.
187. Senderovitz T, Viskum K.Corticosteroids and tuberculosis. Respir Med. 1994;88:561–5.
188. Syed FF, Schaff HV, Oh JK.Constrictive pericarditis-a curable diastolic heart failure. Nat
Rev Cardiol. 2014;11:530–44.
189. Sagrista-Sauleda J, Angel J. Sa¨nchez A, Permanyer-Miralda G, Soler-Soler. J Effusiveconstrictive pericarditis N Engl J Med. 2004;350:469–75.
190. Salami MA, Adeoye PO, Adegboye VO, Adebo OA.Presentation pattern and management of
effusive-constrictive pericarditis in Ibadan. Cardiovasc J Afr. 2012;23:206–11.
191. Syed FF, Menasche M, Mayosi BM, Oh JK.Effusive-constrictive pericarditis. Heart Fail Rev.
2013;18:277–87.
192. Seferovic PM, Ristic AD, Maksimovic R, Tatic V, Ostojic M, Kanjuh V.Diagnostic value
of pericardial biopsy: improvement with extensive sampling enabled by pericardioscopy.
Circulation. 2003;107:978–83.
193. Smedema JP, Katjitae I, Reuter H, Burgess L, Louw V, Pretorius M, etal. Twelve-lead electrocardiography in tuberculous pericarditis. Cardiovasc J South Afr. 2001;12:31–4.
194. Srivastava AK, Ganjoo AK, Misra B, Chaterjee T, Kapoor A, Pandey CM. Subtotal pericardiectomy via sternotomy for constrictive pericarditis. Asian Cardiovasc Thorac Ann.
2000;8:134–6.
195. Syed IS, Feng D, Harris SR, Martinez MW, Misselt AJ, Breen JF, etal. MR imaging of cardiac masses. Magn Reson Imaging Clin N Am. 2008;16:137–64.
353
354
https://t.me/medicina_free
196. Soler-Soler J, Sagristà-Sauleda J, Permanyer-Miralda G.Management of pericardial effusion. Heart. 2001;86:235–40.
197. Soler-Soler J, Sagristà-Sauleda J, Permanyer-Miralda G. Relapsing pericarditis. Heart.
2004;90:1364–8.
198. Soler-Soler J, Sagrista-Sauleda J, Permanyer-Miralda G. Aetiologic diagnosis of pericardial disease: worthy efforts may not be applied in the appropriate direction. Eur Heart
J. 2006;16:1898–9.
199. Soler-Soler J, Sagrista-Sauleda J, Permanyer-Miralda G. Relapsing pericarditis. Heart.
2004;90:1364–8.
200. Spodick DH, Kumar S. Subacute constrictive pericarditis with tamponade. Dis Chest.
1968;54:62–6.
201. Shabetai R. Recurrent pericarditis. Recent advances and remaining questions Circulation.
2005;112:1921–3.
202. Sagrista-Sauleda J, Angel J, Sambola A, Permanyer-Miralda G.Haemodynamic effects of
volume expansion in patients with cardiac tamponade. Circulation. 2008;117:1545–54.
203. Tirilomis T, Unverdorben S, von der Emde J.Pericardectomy for chronic constrictive pericarditis: risks and outcome. Eur J Cardiothorac Surg. 1994;8:487–92.
204. Trautner BW, Darouiche RO.Tuberculous pericarditis: optimal diagnosis and management.
Clin Infect Dis. 2001;33:954–61.
205. Tuon FF, Litvoc MN, Lopes MIBF.Adenosine deaminase and tuberculous pericarditis-a systematic review with meta-analysis. Acta Trop. 2006;99:67–74.
206. Tsang TS, Seward JB, Barnes ME, Bailey KR, Sinak LJ, Urban LH, etal. Outcomes of primary and secondary treatment of pericardial effusion in patients with malignancy. Mayo Clin
Proc. 2000;75:248–53.
207. Uthaman B, Endrys J, Abushaban L, etal. Percutaneous pericardial biopsy: technique, efcacy, safety, and value in the management of pericardia 1 effusion in children and adolescents. Pediatr Cardiol. 1997;18:414–8.
208. Viola AR.The inuence of pericardiectomy on the haemodynamics of chronic constrictive
pericarditis. Circulation. 1973;48:1038–42.
209. Wiysonge CS, Ntsekhe M, Gumedze F, et al. Contemporary use of adjunctive corticosteroids in tuberculous pericarditis Int J Cardiol 2007 (in press). https://doi.org/10.1016/j.
ijcard.2006.12.060, 388, 390, 124.
210. Wiysonge CS, Ntsekhe M, Gumedze F, etal. Excess mortality in presumed tuberculous pericarditis. Eur Heart J. 2006;27:958.
211. Williams IP, Hetzel MR.Tuberculous pericarditis in south-West London: an increasing problem. Thorax. 1978;33:816–7.
212. Wood JA.Tuberculous pericarditis; a study of fortyone cases with special reference to prognosis. Am Heart J. 1951;42:737–45.
213. World Health Organization. Treatment of Tuberculosis. Guidelines. WHO/HTM/TB/2009.
420 4th ed. Geneva: World Health Organization; 2010.
214. Woods T, Vidarsson B, Mosher D, Stein JH.Transicnt effusivc-constrictive pericarditis due
to chemotherapy. Clin Cardiol. 1999;22:316–8.
215. Yanase O, Motomiya T, Watanabe K, Tokuyasu Y, Sakurada H, Tejima T, Hiyoshi Y, Sugiura
M, Yabata Y, Kitazumi H.Lassa fever associated with effusive-constrictive pericarditis and
bilateral atrioventricular annular constriction: a case report. J Cardiol. 1989;19:1147–56.
216. Zayas R, Anguita M, Torres F, Gimenez D, Bergillos F, Ruiz M, etal. Incidence of specic
aetiology and role of methods for specic etiologic diagnosis of primary acute pericarditis.
Am J Cardiol. 1995;75:378–82.
217. Zumla A, Malon P, Henderson J, Grange JM. Impact of HIV infection on tuberculosis.
Postgrad Med J. 2000;76:259–68.
20 Specic Disease Entities
Соседние файлы в папке Библиотека им академика М.И. Перельмана